查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2028 年歐洲藥物輸送市場預測 - COVID-19 影響和區域分析 - 按給藥途徑、配銷通路和最終用戶
市場調查報告書
商品編碼
1375079

2028 年歐洲藥物輸送市場預測 - COVID-19 影響和區域分析 - 按給藥途徑、配銷通路和最終用戶

Europe Drug Delivery Market Forecast to 2028- COVID-19 Impact and Regional Analysis- by Route of Administration, Distribution Channel, and End User
出版日期: | 出版商: The Insight Partners | 英文 247 Pages | 訂單完成後即時交付

價格

歐洲給藥市場預計將從2023年的6322.6846億美元成長到2028年的8953.3887億美元。預計2023年至2028年年複合成長率為7.2%。

對非侵入性給藥系統不斷成長的需求推動了歐洲給藥市場

非侵入性藥物遞送通常是指穿過黏膜表面或皮膚的生物屏障的無痛藥物遞送方法。這種藥物傳遞方法可以改善藥物的取得、治療方案的依從性以及更好的藥物安全性。由於與注射給藥相比具有明顯的優勢，患者更喜歡非侵入性給藥途徑。研究發現，透過非侵入性方法給藥時，患者的依從性要高得多，因為他們在手術過程中感受到的疼痛減輕了。隨著醫療設備和經皮給藥技術的改進，非侵入性給藥方式現已準備好與傳統的口服和注射給藥途徑競爭。局部給藥、經皮主動給藥（裝置輔助增強滲透）、經皮被動給藥、經眼膜、跨黏膜以及吸入藥物經由肺泡膜給藥是一些流行的非侵入性給藥方法。

低排斥率、易於給藥、便利性和耐用性使 TDDS 成為最具吸引力的藥物傳遞方法。除了醫療機構的藥物管理之外，TDDS 還可用於護膚行業的不同程序。由於此方法主要涉及局部給藥，因此可以防止藥物非特異性地遞送至非標靶組織。 TDDS 的發展可能有助於控制心血管和中樞神經系統疾病、遺傳性疾病、糖尿病、神經肌肉疾病和傳染病（包括局部疾病）的盛行率，同時推動疫苗接種的進步和患者對長期自我給藥的偏好- 長期治療。

透過非侵入性方法輸送藥物涉及減少給藥頻率和簡化給藥方案。此外，這些輸送系統可以顯著降低臨床使用成本，因為患者可以透過這些方法自行給藥。在許多情況下，採用非侵入性給藥系統的藥物的製造成本低於注射劑的生產成本。例如，吸入胰島素已成為治療糖尿病的耐受性良好且首選的方式。因此，對非侵入性藥物輸送系統不斷成長的需求推動了藥物輸送系統市場的成長。

歐洲藥物輸送市場概況

歐洲給藥市場細分為德國、法國、義大利、英國、西班牙和歐洲其他地區。該地區的市場成長與慢性病發病率的上升、老年人口的增加、市場參與者的擴張策略以及製藥業的成長有關。德國以其技術進步而聞名，在醫療保健領域處於領先地位。 Haselmeier 等德國公司開發了 D-Flex 筆，這是一種比以前開發的注射筆更有效的藥物輸送裝置。該筆是用於皮下自我注射的下一代藥物輸送裝置。多劑量固定筆可以單次固定劑量或多個預設劑量給藥；因此，它優於傳統的藥物輸送裝置。

歐洲給藥市場收入及 2028 年預測（百萬美元）

歐洲藥物輸送市場細分

歐洲給藥市場分為給藥途徑、配銷通路、最終用戶和國家。

根據給藥途徑，歐洲給藥市場分為注射給藥、口服給藥、經黏膜給藥、局部給藥、植入式給藥及眼部給藥。 2023年，注射給藥細分市場在歐洲給藥市場中佔有更大佔有率。

根據配銷通路，歐洲給藥市場分為醫院藥房、零售藥房和線上藥房。 2023 年，醫院藥局領域在歐洲給藥市場中佔據最大佔有率。

根據最終用戶，歐洲給藥市場分為醫院和診所、家庭護理機構和其他最終用戶。 2023 年，醫院和診所領域在歐洲給藥市場中佔最大佔有率。

根據國家/地區，歐洲給藥市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2023年，德國在歐洲給藥市場佔有率中佔據主導地位。

博士健康公司；百特國際公司；貝克頓·迪金森公司；勃林格殷格翰國際股份有限公司；波士頓科學公司；格雷斯海默股份公司；葛蘭素史克公司；強生公司；諾華公司；諾和諾德公司；輝瑞公司；和 Sever Pharma Solutions 是歐洲給藥市場的領導公司。

目錄

第 1 章：簡介

  • 研究範圍
  • Insight Partners 研究報告指南
  • 市場區隔
    • 歐洲藥物輸送市場 - 按給藥途徑
    • 歐洲藥物輸送市場 - 按配銷通路
    • 歐洲藥物輸送市場 - 按最終用戶分類
    • 歐洲藥物輸送市場 - 按國家/地區

第 2 章：歐洲藥物輸送市場 - 要點

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲藥物輸送市場 - 市場格局

  • 概述
  • 歐洲PEST分析
  • 專家意見

第 5 章：歐洲藥物輸送市場 - 主要市場動態

  • 市場促進因素
    • 慢性病發生率上升
    • 對非侵入性給藥系統的需求不斷成長
    • 藥廠研發支出增加
  • 主要市場限制
    • 與藥物和輸送系統開發相關的高成本
    • 藥物輸送系統中的產品召回
  • 主要市場機會
    • 專注於提高病患依從性
  • 未來的趨勢
    • 策略發展和產品發布
  • 影響分析

第 6 章：藥物輸送市場 - 歐洲分析

  • 歐洲給藥市場收入預測與分析

第 7 章：歐洲藥物輸送市場 - 2028 年收入和預測 - 按給藥途徑

  • 概述
  • 歐洲藥物輸送市場收入佔有率，依給藥途徑分類（2022 年和 2028 年）
  • 注射給藥
  • 口服給藥
  • 局部給藥
  • 經由黏膜給藥
  • 植入式藥物輸送
  • 眼部藥物輸送

第 8 章：歐洲藥物輸送市場 - 收入和 2028 年預測 - 按配銷通路

  • 概述
  • 歐洲藥物輸送系統市場收入佔有率，按配銷通路分類（2022 年和 2028 年）
  • 醫院藥房
  • 零售藥局
  • 網路藥局

第 9 章：歐洲藥物輸送市場 - 收入和 2028 年預測 - 按最終用戶

  • 概述
  • 歐洲藥物輸送系統市場收入佔有率，按最終用戶分類（2022 年和 2028 年）
  • 醫院和診所
  • 家庭護理設置
  • 其他最終用戶

第 10 章：歐洲藥物輸送市場 - 2028 年收入與預測 - 國家分析

      • 英國
      • 德國
      • 法國
      • 西班牙
      • 義大利
      • 歐洲其他地區

第 11 章：歐洲藥物輸送市場 - 產業格局

  • 概述
  • 歐洲給藥市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 12 章：公司簡介

  • Becton Dickinson and Co
  • Novo Nordisk AS
  • Boston Scientific Corp
  • Baxter International Inc
  • Gerresheimer AG
  • GlaxoSmithKline Plc
  • 博士健康公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 勃林格殷格翰國際股份有限公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 諾華公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 塞弗製藥解決方案
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 強生公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展
  • 輝瑞公司
    • 主要事實
    • 業務描述
    • 產品與服務
    • 財務概覽
    • SWOT分析
    • 主要進展

    第 13 章：附錄

    • 關於 Insight Partners
    • 專業術語
    • Product Code: BMIRE00028754

    The Europe drug delivery market is expected to grow from US$ 6,32,268.46 million in 2023 to US$ 8,95,338.87 million by 2028. It is estimated to grow at a CAGR of 7.2% from 2023 to 2028.

    Growing Demand for Noninvasive Drug Delivery Systems Fuel Europe Drug Delivery Market

    Noninvasive drug delivery generally refers to methods of painless drug delivery across the biological barriers of mucosal surfaces or skin. This drug delivery method could lead to improved access to medicines, adherence to treatment regimes, and better drug safety profiles. Patients prefer noninvasive drug delivery routes due to such apparent advantages over injection-based drug administration. Patient compliance has been found to be much higher when drugs are administrated by noninvasive methods, as they experience decreased pain during the procedure. With improvements in medical devices and transdermal delivery technologies, the noninvasive mode of drug delivery is now ready to compete with traditional methods of oral and injectable routes of drug delivery. Topical, transdermal-active (device-aided enhanced penetration), transdermal-passive, trans-ocular membrane, trans-mucosal membrane, and delivery via an alveolar membrane from inhaled medication are a few of the popular noninvasive drug delivery methods.

    A low rejection rate, ease of administration, convenience, and durability make TDDS the most attractive method of drug delivery. In addition to pharmaceutical administration in medical facilities, TDDS could be used in different procedures in the skincare industry. Since this method mainly involves local administration, it can prevent nonspecific delivery to tissues that are not targeted by the drug. Developments in TDDS are likely to help control the prevalence of cardiovascular and central nervous system disorders, genetic disorders, diabetes, neuromuscular disorders, and infectious (including localized conditions) diseases while driving advancements in vaccination and patient preference for self-administration of drugs for long-term treatment.

    Drug delivery through noninvasive methods involves reduced dosing frequency and simplified dosing schedules. Moreover, these delivery systems can significantly reduce the cost of clinical use as patients can self-administer drugs via these methods. In many cases, the manufacturing cost of drugs with noninvasive delivery systems is lesser than the production costs of injections. For instance, inhaled insulin has emerged as a well-tolerated and preferred modality for treating diabetes. Thus, the growing demand for noninvasive drug delivery systems propels the growth of the drug delivery systems market.

    Europe Drug Delivery Market Overview

    The Europe drug delivery market is sub segmented into Germany, France, Italy, the UK, Spain, and the Rest of Europe. The market growth in this region is associated with rise in incidences of chronic diseases, increase in the geriatric population, expansion strategies by the market players, and growth of the pharmaceutical industry. Germany is known for its technological advancements, leading the country to the forefront in the medical & healthcare sectors. German companies such as Haselmeier have developed the D-Flex pen, a drug delivery device that works more efficiently than previously developed injection pens. The pen is the next-generation drug delivery device for subcutaneous self-injection. The multi-dose fixed pen can administer the drug in a single fixed dose or several pre-set doses; therefore, it is preferred over conventional drug delivery devices.

    Europe Drug Delivery Market Revenue and Forecast to 2028 (US$ Million)

    Europe Drug Delivery Market Segmentation

    The Europe drug delivery market is segmented into route of administration, distribution channel, end user, and country.

    Based on route of administration, the Europe drug delivery market is segmented into injectable drug delivery, oral drug delivery, transmucosal drug delivery, topical drug delivery, implantable drug delivery, and ocular drug delivery. The injectable drug delivery segment held a larger share of the Europe drug delivery market in 2023.

    Based on distribution channel, the Europe drug delivery market is segmented into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the Europe drug delivery market in 2023.

    Based on end user, the Europe drug delivery market is segmented into hospitals and clinics, home care settings, and other end user. The hospitals and clinics segment held the largest share of the Europe drug delivery market in 2023.

    Based on country, the Europe drug delivery market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Germany dominated the share of the Europe drug delivery market in 2023.

    Bausch Health Companies Inc; Baxter International Inc; Becton Dickinson and Co; Boehringer Ingelheim International GmbH; Boston Scientific Corp; Gerresheimer AG; GlaxoSmithKline Plc; Johnson & Johnson; Novartis AG; Novo Nordisk AS; Pfizer Inc; and Sever Pharma Solutions are the leading companies operating in the Europe drug delivery market.

    Reasons to Buy:

    • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe drug delivery market.
    • Highlights key business priorities in order to assist companies to realign their business strategies.
    • The key findings and recommendations highlight crucial progressive industry trends in Europe drug delivery market, thereby allowing players across the value chain to develop effective long-term strategies.
    • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
    • Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the market, as well as those hindering it.
    • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

    Table Of Contents

    1. Introduction

    • 1.1 Study Scope
    • 1.2 The Insight Partners Research Report Guidance
    • 1.3 Market Segmentation
      • 1.3.1 Europe Drug Delivery Market - by Route of Administration
      • 1.3.2 Europe Drug Delivery Market - by Distribution Channel
      • 1.3.3 Europe Drug Delivery Market - by End User
      • 1.3.4 Europe Drug Delivery Market - by Country

    2. Europe Drug Delivery Market - Key Takeaways

    3. Research Methodology

    • 3.1 Coverage
    • 3.2 Secondary Research
    • 3.3 Primary Research

    4. Europe Drug Delivery Market - Market Landscape

    • 4.1 Overview
    • 4.2 Europe PEST Analysis
    • 4.3 Expert's Opinion

    5. Europe Drug Delivery Market - Key Market Dynamics

    • 5.1 Market Drivers
      • 5.1.1 Rising Incidence of Chronic Diseases
      • 5.1.2 Growing Demand for Noninvasive Drug Delivery Systems
      • 5.1.3 Increasing R&D Expenditures in Pharmaceutical Companies
    • 5.2 Key Market Restraints
      • 5.2.1 High Cost Associated with Development of Drugs and Delivery Systems
      • 5.2.2 Product Recalls in Drug Delivery Systems
    • 5.3 Key Market Opportunities
      • 5.3.1 Focus on Improving Patient Compliance
    • 5.4 Future Trends
      • 5.4.1 Strategic Developments and Product Launches
    • 5.5 Impact analysis

    6. Drug Delivery Market -Europe Analysis

    • 6.1 Europe Drug Delivery Market Revenue Forecast and Analysis

    7. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Route of Administration

    • 7.1 Overview
    • 7.2 Europe Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
    • 7.3 Injectable Drug Delivery
      • 7.3.1 Overview
      • 7.3.2 Injectable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.3.2.1 Conventional Injection Devices
          • 7.3.2.1.1 Overview
          • 7.3.2.1.2 Conventional Injection Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.3.2.2 Advanced Devices
          • 7.3.2.2.1 Overview
          • 7.3.2.2.2 Advanced Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.4 Oral Drug Delivery
      • 7.4.1 Overview
      • 7.4.2 Oral Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.1 Solid Oral Drugs
          • 7.4.2.1.1 Overview
          • 7.4.2.1.2 Solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.2 Liquid Oral Drugs
          • 7.4.2.2.1 Overview
          • 7.4.2.2.2 Liquid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.4.2.3 Semi-solid Oral Drugs
          • 7.4.2.3.1 Overview
          • 7.4.2.3.2 Semi-solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.5 Topical Drug Delivery
      • 7.5.1 Overview
      • 7.5.2 Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.1 Semi-solid Topical Drug Delivery
          • 7.5.2.1.1 Overview
          • 7.5.2.1.2 Semi-solid Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.2 Liquid Topical Drug Delivery Formulations
          • 7.5.2.2.1 Overview
          • 7.5.2.2.2 Liquid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.3 Solid Topical Drug Delivery Formulations
          • 7.5.2.3.1 Overview
          • 7.5.2.3.2 Solid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.5.2.4 Transdermal
          • 7.5.2.4.1 Overview
          • 7.5.2.4.2 Transdermal Patches: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.6 Transmucosal Drug Delivery
      • 7.6.1 Overview
      • 7.6.2 Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.1 Pulmonary and Nasal Drug Delivery
          • 7.6.2.1.1 Overview
          • 7.6.2.1.2 Pulmonary and Nasal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.2 Buccal and Sublingual Drug Delivery
          • 7.6.2.2.1 Overview
          • 7.6.2.2.2 Buccal and Sublingual Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.3 Rectal Transmucosal Drug Delivery
          • 7.6.2.3.1 Overview
          • 7.6.2.3.2 Rectal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.6.2.4 Vaginal Transmucosal Drug Delivery
          • 7.6.2.4.1 Overview
          • 7.6.2.4.2 Vaginal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.7 Implantable Drug Delivery
      • 7.7.1 Overview
      • 7.7.2 Implantable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • 7.8 Ocular Drug Delivery
      • 7.8.1 Overview
      • 7.8.2 Ocular Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.1 Eye Drops and Sprays
          • 7.8.2.1.1 Overview
          • 7.8.2.1.2 Eye Drops and Sprays: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.2 Gels and Ointments
          • 7.8.2.2.1 Overview
          • 7.8.2.2.2 Gels and Ointments: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.3 Ocular Inserts and Punctal Plugs
          • 7.8.2.3.1 Overview
          • 7.8.2.3.2 Ocular Inserts and Punctal Plugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
        • 7.8.2.4 Therapeutic Contact Lens
          • 7.8.2.4.1 Overview
          • 7.8.2.4.2 Therapeutic Contact Lens: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)

    8. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By Distribution Channel

    • 8.1 Overview
    • 8.2 Europe Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
    • 8.3 Hospital Pharmacies
      • 8.3.1 Overview
      • 8.3.2 Hospital Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.4 Retail Pharmacies
      • 8.4.1 Overview
      • 8.4.2 Retail Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 8.5 Online Pharmacies
      • 8.5.1 Overview
      • 8.5.2 Online Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

    9. Europe Drug Delivery Market - Revenue and Forecast to 2028 - By End User

    • 9.1 Overview
    • 9.2 Europe Drug Delivery Systems Market Revenue Share, by End User (2022and 2028)
    • 9.3 Hospitals and Clinics
      • 9.3.1 Overview
      • 9.3.2 Hospitals and Clinics: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.4 Home Care Settings
      • 9.4.1 Overview
      • 9.4.2 Home Care Settings: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • 9.5 Other End User
      • 9.5.1 Overview
      • 9.5.2 Other End User: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)

    10. Europe Drug Delivery Market - Revenue and Forecast to 2028 - Country Analysis

    • 10.1 Overview
      • 10.1.1 Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
        • 10.1.1.1 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.1.1 Overview
          • 10.1.1.1.2 UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.1.3 UK: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.1.3.1 UK: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.2 UK: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.3 UK: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.4 UK: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.3.5 UK: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.1.4 UK: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.1.5 UK: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.2.1 Overview
          • 10.1.1.2.2 Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.2.3 Germany: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.2.3.1 Germany: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.2 Germany: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.3 Germany: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.4 Germany: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.3.5 Germany: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.2.4 Germany: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.2.5 Germany: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.3 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.3.1 Overview
          • 10.1.1.3.2 France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.3.3 France: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.3.3.1 France: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.2 France: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.3 France: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.4 France: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.3.5 France: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.3.4 France: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.3.5 France: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.4 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.4.1 Overview
          • 10.1.1.4.2 Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.4.3 Spain: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.4.3.1 Spain: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.2 Spain: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.3 Spain: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.4 Spain: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.3.5 Spain: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.4.4 Spain: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.4.5 Spain: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.5 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.5.1 Overview
          • 10.1.1.5.2 Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.5.3 Italy: Europe Drug Delivery Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.5.3.1 Italy: Europe Drug Delivery Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.2 Italy: Europe Drug Delivery Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.3 Italy: Europe Drug Delivery Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.4 Italy: Europe Drug Delivery Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.3.5 Italy: Europe Drug Delivery Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.5.4 Italy: Europe Drug Delivery Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.5.5 Italy: Europe Drug Delivery Market, by End User 2020-2028 (US$ Million)
        • 10.1.1.6 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.6.1 Overview
          • 10.1.1.6.2 Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
          • 10.1.1.6.3 Rest of Europe: Europe Drug Delivery Systems Market, by Route of Administration, 2020-2028 (US$ Million)
          • 10.1.1.6.3.1 Rest of Europe: Europe Drug Delivery Systems Market, by Injectable Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.2 Rest of Europe: Europe Drug Delivery Systems Market, by Oral Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.3 Rest of Europe: Europe Drug Delivery Systems Market, by Topical Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.4 Rest of Europe: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.3.5 Rest of Europe: Europe Drug Delivery Systems Market, by Ocular Drug Delivery, 2020-2028 (US$ Million)
          • 10.1.1.6.4 Rest of Europe: Europe Drug Delivery Systems Market, by Distribution Channel, 2020-2028 (US$ Million)
          • 10.1.1.6.5 Rest of Europe: Europe Drug Delivery Systems Market, by End User 2020-2028 (US$ Million)

    11. Europe Drug Delivery Market - Industry Landscape

    • 11.1 Overview
    • 11.2 Growth Strategies in Europe Drug Delivery Market
    • 11.3 Organic Growth Strategies
      • 11.3.1 Overview
    • 11.4 Inorganic Growth Strategies
      • 11.4.1 Overview

    12. Company Profiles

    • 12.1 Becton Dickinson and Co
      • 12.1.1 Key Facts
      • 12.1.2 Business Description
      • 12.1.3 Products and Services
      • 12.1.4 Financial Overview
      • 12.1.5 SWOT Analysis
      • 12.1.6 Key Developments
    • 12.2 Novo Nordisk AS
      • 12.2.1 Key Facts
      • 12.2.2 Business Description
      • 12.2.3 Products and Services
      • 12.2.4 Financial Overview
      • 12.2.5 SWOT Analysis
      • 12.2.6 Key Developments
    • 12.3 Boston Scientific Corp
      • 12.3.1 Key Facts
      • 12.3.2 Business Description
      • 12.3.3 Products and Services
      • 12.3.4 Financial Overview
      • 12.3.5 SWOT Analysis
      • 12.3.6 Key Developments
    • 12.4 Baxter International Inc
      • 12.4.1 Key Facts
      • 12.4.2 Business Description
      • 12.4.3 Products and Services
      • 12.4.4 Financial Overview
      • 12.4.5 SWOT Analysis
      • 12.4.6 Key Developments
    • 12.5 Gerresheimer AG
      • 12.5.1 Key Facts
      • 12.5.2 Business Description
      • 12.5.3 Products and Services
      • 12.5.4 Financial Overview
      • 12.5.5 SWOT Analysis
      • 12.5.6 Key Developments
    • 12.6 GlaxoSmithKline Plc
      • 12.6.1 Key Facts
      • 12.6.2 Business Description
      • 12.6.3 Products and Services
      • 12.6.4 Financial Overview
      • 12.6.5 SWOT Analysis
        • 12.6.5.1 Key Developments
    • 12.7 Bausch Health Companies Inc
      • 12.7.1 Key Facts
      • 12.7.2 Business Description
      • 12.7.3 Products and Services
      • 12.7.4 Financial Overview
      • 12.7.5 SWOT Analysis
      • 12.7.6 Key Developments
    • 12.8 Boehringer Ingelheim International GmbH
      • 12.8.1 Key Facts
      • 12.8.2 Business Description
      • 12.8.3 Products and Services
      • 12.8.4 Financial Overview
      • 12.8.5 SWOT Analysis
      • 12.8.6 Key Developments
    • 12.9 Novartis AG
      • 12.9.1 Key Facts
      • 12.9.2 Business Description
      • 12.9.3 Products and Services
      • 12.9.4 Financial Overview
      • 12.9.5 SWOT Analysis
      • 12.9.6 Key Developments
    • 12.10 Sever Pharma Solutions
      • 12.10.1 Key Facts
      • 12.10.2 Business Description
      • 12.10.3 Products and Services
      • 12.10.4 Financial Overview
      • 12.10.5 SWOT Analysis
      • 12.10.6 Key Developments
    • 12.11 Johnson & Johnson
      • 12.11.1 Key Facts
      • 12.11.2 Business Description
      • 12.11.3 Products and Services
      • 12.11.4 Financial Overview
      • 12.11.5 SWOT Analysis
      • 12.11.6 Key Developments
    • 12.12 Pfizer Inc
      • 12.12.1 Key Facts
      • 12.12.2 Business Description
      • 12.12.3 Products and Services
      • 12.12.4 Financial Overview
      • 12.12.5 SWOT Analysis
      • 12.12.6 Key Developments

    13. Appendix

    • 13.1 About The Insight Partners
    • 13.2 Glossary of Terms

    List Of Tables

    • Table 1. UK: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 2. UK: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 3. UK: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 4. UK: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 5. UK: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 6. UK: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 7. UK: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 8. UK: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 9. Germany: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 10. Germany: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 11. Germany: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 12. Germany: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 13. Germany: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 14. Germany: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 15. Germany: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 16. Germany: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 17. France: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 18. France: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 19. France: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 20. France: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 21. France: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 22. France: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 23. France: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 24. France: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 25. Spain: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 26. Spain: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 27. Spain: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 28. Spain: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 29. Spain: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 30. Spain: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 31. Spain: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 32. Spain: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 33. Italy: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 34. Italy: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 35. Italy: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 36. Italy: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 37. Italy: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 38. Italy: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 39. Italy: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 40. Italy: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 41. Rest of Europe: Europe Drug Delivery Systems Market, by Route of Administration - Revenue and Forecast to 2028 (US$ Million)
    • Table 42. Rest of Europe: Europe Drug Delivery Systems Market, by Injectable Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 43. Rest of Europe: Europe Drug Delivery Systems Market, by Oral Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 44. Rest of Europe: Europe Drug Delivery Systems Market, by Topical Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 45. Rest of Europe: Europe Drug Delivery Systems Market, by Transmucosal Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 46. Rest of Europe: Europe Drug Delivery Systems Market, by Ocular Drug Delivery - Revenue and Forecast to 2028 (US$ Million)
    • Table 47. Rest of Europe: Europe Drug Delivery Systems Market, by Distribution Channel- Revenue and Forecast to 2028 (US$ Million)
    • Table 48. Rest of Europe: Europe Drug Delivery Systems Market, by End User - Revenue and Forecast to 2028 (US$ Million)
    • Table 49. Recent Organic Growth Strategies in Europe Drug Delivery Market
    • Table 50. Recent Inorganic Growth Strategies in the Europe Drug Delivery Market
    • Table 51. Glossary of Terms, Europe Drug delivery market

    List Of Figures

    • Figure 1. Europe Drug Delivery Market Segmentation
    • Figure 2. Europe Drug Delivery Market by Country
    • Figure 3. Europe Drug Delivery Market Overview
    • Figure 4. Injectable Drug Delivery to Hold the Largest Share of Route of Administration Segment in Europe Drug Delivery Market
    • Figure 5. Germany Expected to Show Remarkable Growth During Forecast Period
    • Figure 6. Europe: PEST Analysis
    • Figure 7. Experts' Opinion
    • Figure 8. Europe Drug Delivery Market Impact Analysis of Drivers and Restraints
    • Figure 9. Europe Drug Delivery Market - Revenue Forecast and Analysis - 2020-2028
    • Figure 10. Europe Drug Delivery Market Revenue Share, by Route of Administration (2022 and 2028)
    • Figure 11. Injectable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 12. Conventional Injection Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 13. Advanced Devices: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 14. Oral Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 15. Solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 16. Liquid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 17. Semi-solid Oral Drugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 18. Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 19. Semi-solid Topical Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 20. Liquid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 21. Solid Topical Drug Delivery Formulations: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 22. Transdermal Patches: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 23. Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 24. Pulmonary Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 25. Buccal and Sublingual Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 26. Rectal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 27. Vaginal Transmucosal Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 28. Implantable Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 29. Ocular Drug Delivery: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 30. Eye Drops and Sprays: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 31. Gels and Ointments: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 32. Ocular Inserts and Punctal Plugs: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 33. Therapeutic Contact Lens: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 34. Europe Drug Delivery Systems Market Revenue Share, by Distribution Channel (2022 and 2028)
    • Figure 35. Hospital Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 36. Retail Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 37. Online Pharmacies: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 38. Europe Drug Delivery Systems Market Revenue Share, by End User (2022 and 2028)
    • Figure 39. Hospitals and Clinics: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 40. Home Care Settings: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 41. Other End User: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 42. Europe Drug Delivery Systems Market, by Key Country - Revenue (2022) (US$ Million)
    • Figure 43. Europe Drug Delivery Systems Market, by Country, 2022 & 2028 (%)
    • Figure 44. UK: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 45. Germany: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 46. France: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 47. Spain: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 48. Italy: Europe Drug Delivery Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 49. Rest of Europe: Europe Drug Delivery Systems Market - Revenue and Forecast to 2028 (US$ Million)
    • Figure 50. Growth Strategies in Europe Drug Delivery Market